Top Markets
#1 Glidr Glidr +51.75%
#2 DOVU DOVU +47.62%
#3 Akedo Akedo +43.85%
#4 Velvet Velvet +39.70%
#5 Black Phoenix Black Phoenix +34.25%
#6 Cross Cross +26.33%
#7 Perle Perle +18.76%
#8 Cysic Cysic +18.58%
#9 Bitway Bitway +15.04%
#10 QANplatform QANplatform +14.82%
Coin of the day
Glidr Glidr
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Chimeric Therapeutics Limited Chimeric Therapeutics Limited

Chimeric Therapeutics Limited

CHM
Classement en actions #38382
Chimeric Therapeutics Ltd. is an Australian clinical-stage biopharmaceutical... Chimeric Therapeutics Ltd. is an Australian clinical-stage biopharmaceutical firm dedicated to developing and commercializing a diverse array of cell therapies designed to combat various cancers. Its lead natural killer (NK) cell platform, CHM 0201, is currently undergoing Phase I clinical evaluation for both solid tumors and hematological malignancies. Another key candidate, CHM 1101 (a CLTX CAR T therapy), is also in Phase I trials, specifically targeting recurrent or progressive glioblastoma in patients expressing MMP2+. Beyond these, the company's development pipeline encompasses CHM 0301 for blood cancers; CLTX CAR NK (CHM 1301) and CDH17 CAR NK (CHM 2301) for solid tumors. The CLTX CAR T platform (CHM 1101) is additionally being investigated for melanoma, colorectal, and prostate cancers, while CDH17 CAR T (CHM 2101) is being developed for neuroendocrine, colorectal, pancreatic, and gastric cancers. Chimeric Therapeutics, headquartered in Carlton, Australia, was founded in 2020.
Prix de l'action
$0.02468497
Capitalisation boursière
$1.01M
Changement (1 jour)
-12.50%
Changement (1 an)
-87.34%
Pays
AU
Échange Chimeric Therapeutics Limited (CHM)

Catégorie

Healthcare
Le prix CHM avec la capitalisation boursière de B
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
CHM
$0.02468497
Capitalisation boursière de Chimeric Therapeutics Limited(CHM)
Capitalisation boursière: $1.01M
En August 2026, Chimeric Therapeutics Limited a une capitalisation boursière de $1.01M. Cela fait de Chimeric Therapeutics Limited la 38382nd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Chimeric Therapeutics Limited du 2021 au 2026
CHM par rapport au top 5 des plus populaires stocks
Prix pour CHM L’actif B La capitalisation boursière de B Résultats
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$132,828 $1.01M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.452T +538,091,748.10%
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$109,395 $1.01M
Apple Inc. Apple Inc.
AAPL
$4.490T +443,165,964.59%
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$101,526 $1.01M
Alphabet Inc. Alphabet Inc.
GOOG
$4.167T +411,284,931.07%
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$89,686.09 $1.01M
Microsoft Corporation Microsoft Corporation
MSFT
$3.681T +363,322,576.05%
Chimeric Therapeutics Limited Chimeric Therapeutics Limited
$68,977.08 $1.01M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.831T +279,429,381.36%